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Rep|y 
To the Editors: 
We read with interest the letter to the editor by Cav- 
allari and associates regarding endothelial and smooth 
muscle cell preservation i veins with University of Wis- 
consin solution (UWS). Our observation that venous 
endothelium and smooth muscle cells were preserved 
inadequately with UWS 1 was in contrast with the findings 
of Cavallari et al.2, 3 They did not observe a detrimental 
effect of UWS on endothelial and smooth muscle func- 
tion, and they suggested that we found detrimental effects 
because our control tissue was stored for 1 hour. We do 
not agree. Our control tissue responded normally to the 
various agonists as regards the ability to relax and contract 
after a 1-hour incubation period compared with fresh 
saphenous vein tissue. We believe that the tissue, as a con- 
trol, should be exposed to the same incubation time as the 
UWS to accurately compare the responses of both tissues. 
These two studies once again highlight he complex inter- 
actions caused by UWS on the different components of 
the vascular wall and document differences between ves- 
sels from different species. Further work clearly is required 
to understand the interaction of UWS and its possible use 
as a preservation solution for saphenous vein bypass grafts. 
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Regarding "Prospective randomized trials of  carotid 
endarterectomy with pr imary closure and patch 
reconstruction: The problem is power" 
To the Editors: 
We read with interest the results of Dr. Archie's infor- 
mal meta-analysis of the trials of patch angioplasty versus 
primary closure in carotid endarterectomy (J Vasc Surg 
1997;25:1118-9), which he thought provided compelling 
evidence in favor of patching. As part of the Cochrane 
Collaboration Stroke Group, 1 we have produced a formal 
meta-analysis of these trials that we update as new trials 
are published. 2 At least seven relevant rials have been 
published. When we added the preliminary results of the 
trial by AbuRahma et al. (J Vasc Surg 1996;24:998-1007) 
to our previous meta-analysis, we found results that were 
similar to the results from Archie. Patching reduced the 
risk of any stroke within 30 days of surgery by two thirds 
when compared with the primary closure group (1.5% vs 
4.5%, two-tailed p = 0.004) and also reduced the risk of 
any stroke or death within 30 days (2.2% vs 5.2%, two- 
tailed p = 0.007) and the risk of early arterial occlusion 
(0.5% vs 3.9%, two-tailed p < 0.0001). These benefits 
apparently were maintained for several years. 2
However, although we agree that these results are 
promising, we do not believe that they are compelling for 
three reasons. First, the trials were generally of poor qual- 
ity and may have biased the findings in favor of patching. 2 
Only three trials definitely used adequate methods of ran- 
domization that prevent selection bias. 3 In at least four 
trials the clinical outcomes were not assessed as blind to 
treatment allocation, and so the assessment of  minor 
strokes or ultrasound results may have been biased. All 
trials randomized carotid arteries rather than patients, 
and therefore 5% to 10% of patients underwent bilateral 
procedures. In these patients, the events in the two arter- 
ies are not independent, and so standard statistical naly- 
sis is not appropriate 4 In addition, if a patient underwent 
simultaneous bilateral operations and then died or had a 
stroke, the particular procedure that was responsible for 
the event may be difficult to ascertain. Approximately 5% 
